MichaelHSchiffMD

PubMed

• 3 citations
  Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis.
  Omar Jabado, Michael A Maldonado, Michael Schiff, Michael E Weinblatt, Roy Fleischmann, William H Robinson, Aiqing He, Vishal Patel, Alex Greenfield, Jasmine Saini, Da...> ;Rheumatology and Therapy. 2022 Apr 1
• Patient-Reported Outcomes of Baricitinib in Patients with Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
  Michael Schiff, Roy Fleischmann> ;BioMed Central. 2017 Sep 20
• Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-yea...
  Sokolove, J.,Schiff, M.,Fleischmann, R.,Weinblatt, M. E.,Connolly, S. E.,Johnsen, A.,Zhu, J.,Maldonado, M. A.,Patel, S.,Robinson, W. H.,Sokolove, J.,Schiff, M.,Fleisch...> ;Ann. Rheum. Dis.. 2015 Sep 12
• 5 citations
  Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow.
  Macr Michael Schiff Md> ;Current Treatment Options in Rheumatology. 2015 Sep 29
• Use of Oral and Subcutaneous Methotrexate in Rheumatoid Arthritis Patients in the United States.
  Curtis, J. R.,Zhang, J.,Xie, F.,Beukelman, T.,Chen, L.,Fernandes, J.,Ginsberg, S.,Spettell, C.,Yun, H.,Saag, K. G.,Schiff, M.> ;Arthritis Care Res (Hoboken). 2014 Jun 20
• Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial.
  Schiff, M.,Weinblatt, M. E.,Valente, R.,van der Heijde, D.,Citera, G.,Elegbe, A.,Maldonado, M.,Fleischmann, R.> ;Ann. Rheum. Dis.. 2013 Aug 20
• Choosing Wisely: The American College of Rheumatology's Top 5 List of Things Physicians and Patients Should Question.
  Schiff, M. H.> ;Arthritis Care Res (Hoboken). 2013 Jul 16
• Subcutaneous abatacept for the treatment of rheumatoid arthritis.
  Schiff, M.> ;Rheumatology (Oxford). 2013 Jun
• Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study.
  Weinblatt, M. E.,Schiff, M.,Valente, R.,van der Heijde, D.,Citera, G.,Zhao, C.,Maldonado, M.,Fleischmann, R.> ;Arthritis Rheum. 2013 Jan
• Combined anti-tumor necrosis factor-? therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD ...
  Edwards, C. K.,Green, J. S.,Volk, H. D.,Schiff, M.,Kotzin, B. L.,Mitsuya, H.,Kawaguchi, T.,Sakata, K. M.,Cheronis, J.,Trollinger, D.,Bankaitis-Davis, D.,Dinarello, C. ...> ;Front Immunol. 2012
• 57 citations
  Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers
  Loren Laine, Alan Kivitz, Alfonso E. Bello, Amy Y Grahn, Michael Schiff, Ali S. Taha> ;The American Journal of Gastroenterology. 2012 Mar 1
• Integrated safety in tocilizumab clinical trials.
  Schiff, M.H., Kremer, J.M., Jahreis, A., Vernon, E., Isaacs, J.D., van Vollenhoven, R.F.> ;Arthritis Res Ther. 2011
• Persistence with Anti-Tumor Necrosis Factor Therapies in Patients with Rheumatoid Arthritis: Observations from the RADIUS Registry.
  Markenson, J. A.,Gibofsky, A.,Palmer, W. R.,Keystone, E. C.,Schiff, M. H.,Feng, J.,Baumgartner, S. W.> ;J Rheumatol. 2011 Jul
• Rapid Improvement in the Signs and Symptoms of Rheumatoid Arthritis Following Certolizumab Pegol Treatment Predicts Better Longterm Outcomes: Post-hoc Analysis of a Ra...
  > ;J Rheumatol. 2011 Jun
• Preventing the progression from undifferentiated arthritis to rheumatoid arthritis: the clinical and economic implications.
  Schiff, M.H.> ;Am J Manag Care. 2010 Nov
• 71 citations
  Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and longstanding rheumatoid arthritis
  Michael E. Weinblatt, Joan M. Bathon, Joel M. Kremer, Roy Fleischmann, Michael Schiff, Richard J. Martin, Scott Baumgartner, Grace S. Park, Edward L. Mancini, Mark C. ...> ;Arthritis Care & Research. 2010 Oct 18
• Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules ass...
  Koffeman, E.C., Genovese, M., Amox, D., Keogh, E., Santana, E., Matteson, E.L., Kavanaugh, A., Molitor, J.A., Schiff, M.H., Posever, J.O., Bathon, J.M., Kivitz, A.J., ...> ;Arthritis Rheum. 2009-11-01
• The 6-Month Safety and Efficacy of Abatacept in Patients with Rheumatoid Arthritis Who Underwent a Washout After Anti-Tumour Necrosis Factor Therapy or Were Directly S...
  K Bahrt, M Schiff> ;Emergency Medicine Journal. 2008 Dec 17
• Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a ...
  Weinblatt, M.E., Schiff, M.H., Ruderman, E.M., Bingham, C.O., Li, J., Louie, J., Furst, D.E.> ;Arthritis Rheum. 2008 Jul
• 96 citations
  Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
  Larry W. Moreland, Michael E. Weinblatt, Edward C. Keystone, Joel M. Kremer, Richard J. Martin, Michael Schiff, James B Whitmore, Barbara White> ;The Journal of Rheumatology. 2006 May 1
• Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al.
  Schiff, M. H.> ;Arthritis Rheum. 2005 Jan
• Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
  Petri, M.A., Mease, P.J., Merrill, J.T., Lahita, R.G., Iannini, M.J., Yocum, D.E., Ginzler, E.M., Katz, R.S., Gluck, O.S., Genovese, M.C., Van Vollenhoven, R., Kalunia...> ;Arthritis Rheum. 2004 Sep
• The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions.
  Schiff, M.H., DiVittorio, G., Tesser, J., Fleischmann, R., Schechtman, J., Hartman, S., Liu, T., Solinger, A.M.> ;Arthritis Rheum. 2004 Jun
• Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
  Keystone, E.C., Schiff, M.H., Kremer, J.M., Kafka, S., Lovy, M., DeVries, T., Burge, D.J.> ;Arthritis Rheum. 2004 Feb
• 3 citations
  Durability and Rapidity of Response to Anakinra in Patients with Rheumatoid Arthritis
  Michael H. Schiff> ;Drugs. 2004 Jan 1
• Join now to see all